A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Condition(s):Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Last Updated:June 18, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Last Updated:June 18, 2021Terminated
Condition(s):Coronary Artery DiseaseLast Updated:June 15, 2011Unknown status
Condition(s):Coronary Artery StenosisLast Updated:June 14, 2011Withdrawn
Condition(s):Vascular Access Complication; Hemodialysis Access Failure (Disorder)Last Updated:November 14, 2022Active, not recruiting
Condition(s):Peripheral Arterial Disease; Cardiovascular DiseasesLast Updated:March 13, 2024Recruiting
Condition(s):Carotid Artery StenosisLast Updated:February 28, 2023Active, not recruiting
Condition(s):Lower Limb IschemiaLast Updated:October 20, 2017Unknown status
Condition(s):Transradial CatheterizationLast Updated:March 3, 2016Completed
Condition(s):Myocardial Infarction; Coronary Revascularization; Acute Renal FailureLast Updated:March 12, 2024Completed
Condition(s):Angioplasty; Peripheral Arterial Disease; Drug-eluting Balloon; Femoral Artery; PaclitaxelLast Updated:February 11, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.